Back to Journals » Journal of Asthma and Allergy » Call For Papers
Journal of Asthma and Allergy
The following Article Collection/ Thematic Series is currently open for submissions:
Artificial Intelligence and Machine Learning to Aid the Management of Allergic Respiratory Diseases
Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Artificial Intelligence and Machine Learning to Aid the Management of Allergic Respiratory Diseases” organized by Guest Advisors Professor Gang Luo and Dr Syed Ahmar Shah in the Journal of Asthma and Allergy.
Recent advances in artificial intelligence (AI) and machine learning (ML) have led to major innovations and fundamental changes in many fields of medicine. Like the case with many other areas in healthcare, AI and ML have immense potential to improve the management of allergic respiratory diseases such as asthma. Asthma is a heterogenous condition encompassing several diseases and current approaches to asthma management are sub-optimal.
Adopting tools built using AI and ML can help identify disease phenotypes, stratify patients based on risk and therefore support personalized treatments that are anticipated to lead to better patient outcomes and reduced healthcare costs.
This Article Collection aims to bring together original research articles, review articles, viewpoint articles, and research protocol articles on using AI and ML (including deep learning) to develop predictive models that can aid the management of allergic respiratory diseases such as asthma. Potential topics include studies that use AI and ML to aid the management of allergic respiratory diseases. Potential topics include the following aspects of AI and ML:
• Development and validation of prognostic tools
• External validation of existing prognostic models
• Clinical implementation of prognostic models
• Benefits and caveats of using explainable AI in clinical decision-making
• Using AI and ML for phenotyping such as age based phenotyping
• Clinical evaluation of prognostic models
• Implementing AI into clinical guidelines such as NHLBI or GINA
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.
The deadline for submissions is 18 October 2023.
Please submit your manuscript on our website, quoting the promo code UJWIV to indicate that your submission is for consideration in this Article Collection.
Call For Papers
To see where the Journal of Asthma and Allergy is indexed online view the Journal Metrics.
What is the advantage to you of publishing in the Journal of Asthma and Allergy?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Although the Journal of Asthma and Allergy receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. The Journal of Asthma and Allergy has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
The Journal of Asthma and Allergy is indexed on PubMed Central (title abbreviation: J Asthma Allergy). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.
Amrita Dosanjh, MD
Journal of Asthma and Allergy